Axsome Therapeutics (AXSM)
Developer of CNS medicines for depression, Alzheimer’s agitation, daytime sleepiness, and migraine.
$195.44
vs last close−7.66 (−3.77%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 70.40% | 36.88M shares | |
|---|---|---|---|
| 539 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.29% | 151.1K shares | |
| 6 holders · as of Aug 7, 2026 | |||
| Other | ≈ 29.31% | 15.35M shares | |
| remainder | |||
52.38M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
539 holders · 36.88M shares · 141 new positions · 300 increased · 163 reduced · 42 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 3.10M | 5.93% | −809.1K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 1.98M | 3.79% | −74.7K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.97M | 3.75% | +27.3K | Aug 13, 2026 |
| Invesco Ltd. | 1.67M | 3.19% | +374.0K | Aug 14, 2026 |
| FMR LLC | 1.54M | 2.94% | −27.8K | Aug 13, 2026 |
| Geode Capital Management, LLC | 967.2K | 1.85% | −195.8K | Aug 12, 2026 |
| Morgan Stanley | 804.1K | 1.54% | +327.4K | Aug 13, 2026 |
| State Street Corp | 785.7K | 1.50% | −201.1K | Aug 7, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 3, 2026 | Mark L. Jacobsonofficer: Chief Operating Officer | Sale | 10,000 | $208.65 | 0 |
| Aug 6, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 4,660 | $213.95 | 7,229 |
| Aug 5, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 45,004 | $212.01 | 7,229 |
| Jul 1, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 49,666 | $240.25 | 7,229 |
| Jun 11, 2026 | Roger Jeffsdirector | Sale | 286 | $249.12 | 58,367 |
| Jun 10, 2026 | Roger Jeffsdirector | Sale | 286 | $246.18 | 58,653 |
| Jun 10, 2026 | Mark Colemandirector | Sale | 643 | $249.00 | 30,389 |
| Jun 10, 2026 | Susan Mahonydirector | Sale | 300 | $246.18 | 829 |
| Jun 9, 2026 | Susan Mahonydirector | Sale | 300 | $237.21 | 1,129 |
| Jun 9, 2026 | Nick Pizzieofficer: Chief Financial Officer | Sale | 33,000 | $240.09 | 42,867 |
House and Senate disclosures
Not reported.